NASDAQ: TGANTransphorm Inc Stock
$4.83+0.00 (+0%)
Updated Apr 25, 2024
TGAN Price
$4.83
Fair Value Price
N/A
Market Cap
$305.58M
52 Week Low
$1.94
52 Week High
$4.96
P/E
-6.9x
P/B
16.74x
P/S
12.1x
PEG
N/A
Dividend Yield
N/A
Revenue
$18.76M
Earnings
-$33.37M
Gross Margin
18.7%
Operating Margin
-176.91%
Profit Margin
-222.3%
Debt to Equity
0.79
Operating Cash Flow
-$22M
Beta
0.74
Next Earnings
Jun 25, 2024
Ex-Dividend
N/A
Next Dividend
N/A
TGAN Overview
Transphorm, Inc., a semiconductor company, develops, manufactures, and sells gallium nitride (GaN) semiconductor components for use in power conversion in Mainland China, Hong Kong, Taiwan, the United States, Japan, South Korea, and Europe. The company's products include GaN field effect transistors in various packages. Its GaN devices allows customers to design power systems creating functional value in various end products, including smartphone power adapters/fast-chargers, power supplies for datacenter servers/communication, industrial power converters, chargers/converters/inverters for electric vehicles, and other applications. The company offers its products through regional distributors and sales representatives. Transphorm, Inc. was founded in 2007 and is headquartered in Goleta, California.
Zen Score
–
Industry Average (38)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TGAN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
TGAN is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TGAN is poor value based on its book value relative to its share price (16.74x), compared to the US Semiconductor Equipment & Materials industry average (11.32x)
P/B vs Industry Valuation
TGAN is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more TGAN due diligence checks available for Premium users.
Be the first to know about important TGAN news, forecast changes, insider trades & much more!
TGAN News
Valuation
TGAN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-6.9x
Industry
38.58x
Market
40.97x
TGAN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
16.74x
Industry
11.32x
TGAN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
TGAN's financial health
Profit margin
Revenue
$4.7M
Net Income
-$10.0M
Profit Margin
-272.4%
TGAN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
TGAN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$32.7M
Liabilities
$14.4M
Debt to equity
0.79
TGAN's short-term assets ($20.95M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TGAN's short-term assets ($20.95M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TGAN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
TGAN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.5M
Investing
-$33.0k
Financing
$2.9M
TGAN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
TGAN vs Semiconductor Equipment Stocks
Transphorm Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.